Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by fdeslogeson Feb 13, 2016 9:59am
353 Views
Post# 24555552

RE:RE:A Prometic Price Study and Takeover Rebuttal

RE:RE:A Prometic Price Study and Takeover Rebuttal

rapid_fire_ wrote: however the laws of the markets says we are long over due.


Ha! The "laws of the market" is supposed to rely on every of its players to be 100% informed. If "the law" of the market were a)right b)at play here, the SP would already be between 9$ and 50$ due to the economic and  DCF analysis I published last week and yesterday.

The laws of the market also expect all players to act anonymously in their own individual interest. It happens that ProMetic history have ruined that anonymity assumption while we were struggling together thru the darkest hour of the post 2008 meltdown. Most of the long shareholders with more than ¼M shares know each other, have met at AGM, talk to each other here or by private emails.

The law of the market is not that blind hand that force people to act against their will! It's real persons being shareholders of ProMetic here. Again, we have:

fdesloges wrote:

  • 3 billionaires each owning 10% or more of PLI.
  • A tight group of Qc+European shareholders, owning 15%
  • PLI's management and close friends, about 5%
  • A group from Western Canada about another 5%
  • Plus all the top oll' longs around here on SH owning > ¼M shares, at least another 5-10% more.
(I'd be really happy to know you by the way, just send me a private message, and let's organise the resistance)

Together the top 100 shareholders control about 60-65% of the stock.
About 20 of them, more than 50%.
If they say no, and you do too, there's no deal. Period.
And that's power indeed. :-)


We large longs write the law of the market regarding PLI.

rapid_fire_ wrote:
Your valuations of SP in mid 2016 calls for 10-15.00 .2017 Q1 25.00 ?  Did I read that correct ? 


The only target price I endorse is that of a minimal 75$ in 2019.
The short term targets above are what I keep hearing around here  is going to make sense if PLI management execute on their plan. We'll see! :-)

rapid_fire_ wrote: Buy a 1000 shares a be a millionaire in 7 years? Would GSK or Roche allow this? 


If we act together there's nothing they can do.
So it depends largely if *you* join us saying No Thanks on their eventual 15$ offer. Will you, rapid_fire ? ;-)

:-D
FD
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse